The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease


  • Nidhi Kanchumarthi
  • Avigail Rockland
  • Thejaswini Vembar
  • Elaine Liu
  • Rithvik Kanaad
  • Erick Torres Hinojosa
  • Kira Tiv
  • Benjamin Chen
  • Shira Hao
  • Sri Guttikonda
  • Ramiro Garza



Alzheimer's disease, Amyloid-beta, Cannabinoids, Tau Protein, Hyperphosphorylation, Δ9-tetrahydrocannabinol, neurodegeneration, endocannabinoid system, inflammation, neurotoxicity, memory deficits, cholinergic system


Alzheimer’s disease (AD) is one of the most prevalent and debilitating neurodegenerative diseases in the world, highlighting the need for research on novel treatments and therapies. Previous studies have found that the body’s endocannabinoid system (ECS) interacts closely with its neural system, making it a potential avenue for the treatment of neurological disorders. One hallmark of AD is the accumulation of amyloid-beta (Aβ) in the brain and its potentially detrimental effects on cognitive function. Cannabis-based drugs have been observed to regulate Aβ modifications and inhibit AD progression. Furthermore, cannabinoids have been noted to reduce inflammation and neurotoxicity. Synthetic cannabinoids were able to rescue memory deficits and neurodegeneration, and reduce immunoreactivity. Similarly, natural cannabinoids like Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) demonstrate therapeutic potential by interacting with the cholinergic system, and reversing the symptoms of AD. Although further research and testing are needed, it is evident that the use of cannabinoids shows promise for future treatment in AD patients.


Download data is not yet available.
The chemical structure of cannabidiol (CBD)




How to Cite

Kanchumarthi, N., Rockland, A., Vembar, T., Liu, E., Kanaad, R., Torres Hinojosa, E., Tiv, K., Chen, B., Hao, S., Guttikonda, S., & Garza, R. (2021). The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease. Berkeley Pharma Tech Journal of Medicine, 1(1), 1–25.



Scientific Review Papers